- Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants With Plantar Fibromatosis
- Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules
- ENDO REPORTS FOURTH-QUARTER 2022 FINANCIAL RESULTS
- Endo Launches "Man With a Plan" Campaign to Support Men With Symptoms of Peyronie's Disease
Key statistics
On Monday, Endo International PLC (ENDPQ:PKC) closed at 0.0788, 37.04% above the 52 week low of 0.0575 set on Dec 19, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.08 |
---|---|
High | 0.084 |
Low | 0.0725 |
Bid | -- |
Offer | -- |
Previous close | 0.085 |
Average volume | 433.53k |
---|---|
Shares outstanding | 235.22m |
Free float | 233.36m |
P/E (TTM) | -- |
Market cap | 19.99m USD |
EPS (TTM) | -12.38 USD |
Data delayed at least 15 minutes, as of Mar 27 2023 20:59 BST.
More ▼